In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography (Q73637666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

1 reference

E O. Aboagye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P M. Price

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Jones

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

293-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

5 November 2019

positron emission tomography

1 reference

Radio-imaging in small animals

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Local cerebral metabolic changes in acute ischemic strokes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

From triazines and triazenes to temozolomide.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

The discovery and profile of fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901684-1

7 January 2021

10.1016/S1359-6446(01)01684-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257581%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference